A third undocumented immigrant detained at a sprawling tent camp in the Texas desert has died, U.S. Immigration and Customs Enforcement announced Sunday, in the third such death in 44 days. Camp East ...

WASHINGTON, Jan 8 (Reuters) - U.S. worker productivity grew at its fastest pace in two years in the third quarter as businesses invested heavily in artificial intelligence, depressing labor costs.

After tariffs rose to the highest levels in centuries, the U.S. lost tens of thousands of manufacturing jobs this year. As part of our video series on Trump’s second term, The Wall Street Journal’s ...

The US economy expanded in the third quarter at the fastest pace in two years, bolstered by resilient consumer and business spending and calmer trade policies. Inflation-adjusted gross domestic ...

The US economy grew at an unexpectedly strong pace of 4.3% in the third quarter — the highest rate in two years — according to a government report released Tuesday. Vigorous consumer spending on ...

Gross domestic product grew at a 4.3 percent annual rate, faster than the previous three months. By Talmon Joseph Smith The U.S. economy grew at a vigorous pace through the end of September, despite ...

An initial reading of third-quarter gross domestic product showed the US economy expanded at an inflation-adjusted annualized rate of 4.3%, a far faster pace than the 3.8% recorded in the second ...

No one won the Powerball jackpot in Wednesday night's drawing. The winning numbers for the December 17 drawing were 25, 33, 53, 62, 66, with a Powerball of 17. Eight tickets matched the first five ...

No one won the Powerball jackpot in Monday night's drawing. Two tickets sold in Arizona and California matched five numbers to win $1 million each. The winning numbers for Monday, Dec. 15, were 23, 35 ...

Fewer than one-third of the individuals arrested by Border Patrol during the Trump administration's recent immigration enforcement crackdown in Charlotte were classified as criminals, according to an ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...